Literature DB >> 20840299

Predictors of clinical remission in cats with diabetes mellitus.

E Zini1, M Hafner, M Osto, M Franchini, M Ackermann, T A Lutz, C E Reusch.   

Abstract

BACKGROUND: Clinical remission is frequent in cats with well-controlled diabetes mellitus, but few studies explored predictors of this phenomenon. HYPOTHESIS: Data retrieved from medical records at admission might be valuable to identify likelihood of remission and its duration in diabetic cats. ANIMALS: Ninety cats with newly diagnosed diabetes, followed-up until death or remission.
METHODS: Retrospective cohort study. Data were collected from records at admission, including history, signalment, physical examination, haematology, and biochemical profile, and the occurrence and duration of remission, defined as normoglycemia without insulin for ≥4 weeks. Predictors of remission were studied with univariate and multivariate logistic regression. Factors associated with remission duration were analyzed with Kaplan-Meier and Cox proportional hazard models.
RESULTS: Forty-five (50%) cats achieved remission, after a median time of 48 days (range: 8-216). By study end, median remission duration was 114 days (range: 30-3,370) in cats that died and 151 days (range: 28-1,180) in alive cats. Remission was more likely with higher age (OR: 1.23, 95% CI: 1.04-1.46; P=.01) and less likely with increased serum cholesterol (OR: 0.36, 95% CI: 0.11-0.87; P=.04). Remission was longer with higher body weight (HR: 0.65, 95% CI: 0.42-0.99; P=.04) and shorter with higher blood glucose (HR: 1.01, 95% CI: 1.00-1.02; P=.02). CONCLUSIONS AND CLINICAL IMPORTANCE: Age, body weight, cholesterol, and glucose levels are suggested for prediction of remission or its duration in diabetic cats. Older cats developing diabetes may have a better outcome, possibly suggesting a slower disease progression.
Copyright © 2010 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Year:  2010        PMID: 20840299     DOI: 10.1111/j.1939-1676.2010.0598.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  15 in total

1.  Diabetic remission in a cat treated with an implantable pump to deliver insulin.

Authors:  Chiara Crinò; Francesca Iavazzo; Filippo Ferri; Luigi M Coppola; Elena Salesov; Thomas A Lutz; Claudia E Reusch; Eric Zini
Journal:  Can Vet J       Date:  2020-01       Impact factor: 1.008

2.  Loose-control of diabetes mellitus with protamine zinc insulin in cats: 185 cases (2005-2015).

Authors:  Lisa M Restine; Gary D Norsworthy; Philip H Kass
Journal:  Can Vet J       Date:  2019-04       Impact factor: 1.008

3.  Intensive intravenous infusion of insulin in diabetic cats.

Authors:  M Hafner; S Dietiker-Moretti; K Kaufmann; C Mueller; T A Lutz; C E Reusch; E Zini
Journal:  J Vet Intern Med       Date:  2014-10-13       Impact factor: 3.333

4.  Glycemic status and predictors of relapse for diabetic cats in remission.

Authors:  S Gottlieb; J S Rand; R Marshall; J Morton
Journal:  J Vet Intern Med       Date:  2014-11-24       Impact factor: 3.333

5.  Longitudinal evaluation of serum pancreatic enzymes and ultrasonographic findings in diabetic cats without clinically relevant pancreatitis at diagnosis.

Authors:  E Zini; M Hafner; P Kook; T A Lutz; S Ohlerth; C E Reusch
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

6.  Differential circulating concentrations of adipokines, glucagon and adropin in a clinical population of lean, overweight and diabetic cats.

Authors:  Rizaldy C Zapata; Melissa D Meachem; Natalia Cavalca Cardoso; Susan O Mehain; Chantal J McMillan; Elisabeth R Snead; Prasanth K Chelikani
Journal:  BMC Vet Res       Date:  2017-04-04       Impact factor: 2.741

7.  Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.

Authors:  M Clark; K Thomaseth; L Dirikolu; D C Ferguson; M Hoenig
Journal:  J Vet Intern Med       Date:  2014 Jan-Feb       Impact factor: 3.333

8.  Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.

Authors:  A Riederer; E Zini; E Salesov; F Fracassi; I Padrutt; K Macha; T M Stöckle; T A Lutz; C E Reusch
Journal:  J Vet Intern Med       Date:  2015-12-24       Impact factor: 3.333

Review 9.  What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.

Authors:  C Gilor; S J M Niessen; E Furrow; S P DiBartola
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

10.  Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.

Authors:  Eric Zini; Elena Salesov; Perrine Dupont; Laura Moretto; Barbara Contiero; Thomas A Lutz; Claudia E Reusch
Journal:  J Vet Intern Med       Date:  2018-03-30       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.